▲ Peaking
Business
Argenx to Buy Forte Biosciences for $2.2 Billion
Argenx is expanding its immunology pipeline through a $2.2 billion acquisition of autoimmune biotech company Forte Biosciences.
1 news trends Newsylist has tracked involving Forte Bio — newest first.
Argenx is expanding its immunology pipeline through a $2.2 billion acquisition of autoimmune biotech company Forte Biosciences.